Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Japan Health Panel Finds No Causal Link Between Tamiflu, Abnormal Behavior (Japan)

This article was originally published in PharmAsia News

Executive Summary

Researchers at Japan's Ministry of Health, Labor and Welfare found no causal link between Roche's anti-flu drug Tamiflu (oseltamivir phosphate) and incidents of abnormal behavior. The group surveyed physicians and relatives of 10,000 flu patients 18 years old and younger, and found 79.3 percent of them took the drug. The survey disclosed symptoms of abnormal behavior in 9.7 percent of patients given Tamiflu and 22 percent of those who did not take the drug. The leader of the researchers cautioned no conclusion could be made until the results are analyzed further. (Click here for more



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts